Caretaker Medical Adds Carbon Dioxide Monitoring to its Wireless Patient Monitoring Platform

Caretaker Medical develops innovative wireless patient monitoring solutions.

Wearable

Technology

Healthcare

Image: Freepik

Caretaker Medical, a Charlottesville, Virginia based wireless medical device company that develops innovative, wireless patient monitoring solutions, announced the addition of wireless ETCO2 (End-Tidal Carbon Dioxide) monitoring to its Caretaker® Finger-Cuff Patient Monitoring Platform that continuously and non-invasively monitors blood pressure and vital signs. The new feature has been integrated using the CMI Health PC900B handheld capnograph and oximeter.

Using the combined Caretaker & ETCO2 solution, clinicians can monitor critical elements of patients’ respiratory status not previously possible in a wireless handheld device with remote data display and reporting. The solution displays the capnograph waveform and numeric ETCO2, FiCO2 (fractional inspired carbon dioxide), respiratory rate, and pulse oximetry on the remote Caretaker tablet App, the company said in a press release.

ETCO2 monitoring offers a breath-to-breath picture and continuous recording of ventilatory effort, endotracheal tube placement and respiratory status. The sidestream nasal cannula fits comfortably on the patient and samples expired carbon dioxide during exhalation, continuously streaming data from the PC900B to the Caretaker display platform.

*CMI Health PC-900B Wireless Handheld ETCO2 Capnograph (Image: Caretaker Health via PrNewswire)*

ETCO2 monitoring is important for monitoring the respiratory status of patients during sedation procedures, including surgery, dental sedation, ambulatory and outpatient procedures, and emergency care.

“In surgical procedures requiring sedation or general anesthesia, it is critical to continuously monitor the patient’s respiratory status. Monitoring End-tidal carbon dioxide provides that ability. I am pleased to see Caretaker has added EtCO2 to their platform of available sensors,” said Dr. Gary H. Chan, DDS, FADSA, Oral & Maxillofacial Surgeon and Dental Anesthesiologist.

Jeff Pompeo, Caretaker Medical’s President & CEO said:

“We continue our commitment to expanding the Caretaker wireless patient monitoring platform with additional parameters. By adding CMI Health’s ETCO2 to our existing CNIBP and Vital Signs parameters, we answered the call of clinicians who asked for wire-free monitoring of this critical respiratory parameter during sedation procedures.”